Pharmaceutical

Drug developers from around the world rang in a new era of sleep medicine Monday, as data from a series of clinical trials show narcolepsy can be effe...

Dive Brief: BioNTech’s experimental bispecific cancer drug pumitamig helped shrink tumors in three-quarters of people with small cell lung cancer who...

Novel orexin receptor agonist shows potential to improve wakefulness Novel orexin receptor agonist shows potential to improve wakefulness

In 2024, Point of Care (POC) marketing surpassed $1 billion1 in revenue — marking a pivotal shift in where marketers are investing their healthcare me...

Artificial intelligence (AI) has quietly become a part of our daily lives – through personalized recommendations, virtual assistants, or smart devices...

Modern obesity trials are inherently complex, but the momentum behind these therapeutics has never been greater. With over $30 billion invested global...

Biomarker testing is foundational to successful targeted and immunotherapy development. From discovery to commercialization, strategic biomarker integ...

Industry watchers who cheered on Summit Therapeutics’ claim that the first global phase 3 trial of its Akeso-partnered PD-1xVEGF drug showed consisten...

Facing increased EGFR competition from a new drug combination by Johnson & Johnson, AstraZeneca has come up with its own solution to prolong the lives...

Hope, when applied with purpose and action, can be a powerful force for driving change. That’s the philosophy of Eugene Woods, CEO of Advocate Health...